CRL Financial Facts
Operating income: 42.76MTotal net sales: 291.24M
See Full Income Statement
Accounts payable: 31.28M
Cash and cash equivalents: 100.42M
See Full Balance Sheet
Earnings History for Charles River Laboratories International, Inc. (CRL)
|
Expand Research on CRL
| Next EPS Date | 8/6/13 *Est. | EPS Growth Rate | -1.4% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +6.3% | Revenue Growth Rate | +1.8% *Last Qtr. |
| Average % Move 1-Wk after EPS | -0.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/13  |
 |
Q113 | $0.69 | $0.71 | -$0.02 | $291.2M | $291.54M | N/A / N/A | = | +4.6% | Details |
| 2/13/13 |
|
Q412 | $0.64 | $0.60 | +$0.04 | $280.1M | $280.81M | N/A / N/A | = | +9.1% | Details |
| 8/7/12 |
|
Q212 | $0.75 | $0.66 | +$0.09 | $284.7M | $286.16M | N/A / N/A |  |
+26.4% | Details |
| 5/2/12 |
|
Q112 | $0.70 | $0.65 | +$0.05 | $286M | $286.21M | N/A / N/A | |
+27.3% | Details |
| 2/13/12 |
|
Q411 | $0.69 | $0.56 | +$0.13 | $291M | $282.76M | N/A / N/A | |
+32.8% | Details |
| 11/1/11 |
|
Q311 | $0.57 | $0.58 | -$0.01 | $277.6M | $280.45M | N/A / N/A | = | +45.1% | Details |
| 8/2/11 |
|
Q211 | $0.70 | $0.60 | +$0.10 | $288.3M | $287.9M | N/A / N/A | = | +19.7% | Details |
| 5/3/11 | Q111 | $0.61 | $0.55 | +$0.06 | $285.8M | $279.17M | N/A / N/A | = | +8.4% | Details |
